175 related articles for article (PubMed ID: 35410241)
1. Health care effects and medical benefits of a smartphone-based diabetes self-management application: study protocol for a randomized controlled trial.
Ehrmann D; Eichinger V; Vesper I; Kober J; Kraus M; Schäfer V; Hermanns N; Kulzer B; Silbermann S
Trials; 2022 Apr; 23(1):282. PubMed ID: 35410241
[TBL] [Abstract][Full Text] [Related]
2. Design of the DAVOS Study: Diabetes Smartphone App, a Fully Automatic Transmission of Data From the Blood Glucose Meter and Insulin Pens Using Wireless Technology to Enhance Diabetes Self-Management-A Study Protocol for a Randomized Controlled Trial.
Grosser F; Herrmann S; Bretschneider M; Timpel P; Schildt J; Bentrup M; Schwarz PEH
J Diabetes Sci Technol; 2023 May; 17(3):742-750. PubMed ID: 35393874
[TBL] [Abstract][Full Text] [Related]
3. An automated structured education intervention based on a smartphone app in Chinese patients with type 1 diabetes: a protocol for a single-blinded randomized controlled trial.
Huang F; Wu X; Xie Y; Liu F; Li J; Li X; Zhou Z
Trials; 2020 Nov; 21(1):944. PubMed ID: 33225982
[TBL] [Abstract][Full Text] [Related]
4. Impact of a smartphone application (KAIA COPD app) in combination with Activity Monitoring as a maintenance prOgram following PUlmonary Rehabilitation in COPD: the protocol for the AMOPUR Study, an international, multicenter, parallel group, randomized, controlled study.
Spielmanns M; Boeselt T; Huber S; Kaur Bollinger P; Ulm B; Peckaka-Egli AM; Jarosch I; Schneeberger T; Schoendorf S; Gloeckl R; Koczulla AR
Trials; 2020 Jul; 21(1):636. PubMed ID: 32653025
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a smartphone application for helping individuals with type 2 diabetes mellitus manage their blood glucose: a protocol for factorial design trial.
Tang H; Qin H; Zhang M; Zhang J; Tan H; Chen M; Kong L; Guo M; Hu F; Wang Q; Wang X; Zhang K; Xiong Z
Trials; 2023 Jul; 24(1):468. PubMed ID: 37480092
[TBL] [Abstract][Full Text] [Related]
6. A smartphone-based intervention for young people who self-harm ('PRIMARY'): study protocol for a multicenter randomized controlled trial.
Aleva A; van den Berg T; Laceulle OM; van Aken MAG; Chanen AM; Betts JK; Hessels CJ
BMC Psychiatry; 2023 Nov; 23(1):840. PubMed ID: 37964199
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a Digital Diabetes Logbook for People With Type 1, Type 2, and Gestational Diabetes: Results From a Multicenter, Open-Label, Parallel-Group, Randomized Controlled Trial.
Ehrmann D; Hermanns N; Finke-Gröne K; Roos T; Kober J; Schäfer V; Krichbaum M; Haak T; Ziegler R; Heinemann L; Rieger C; Bingol E; Kulzer B; Silbermann S
J Diabetes Sci Technol; 2024 Mar; ():19322968241239870. PubMed ID: 38529954
[TBL] [Abstract][Full Text] [Related]
8. Does app-based unguided self-management improve mental health literacy, patient empowerment and access to care for people with mental health impairments? Study protocol for a randomised controlled trial.
Kerber A; Beintner I; Burchert S; Knaevelsrud C
BMJ Open; 2021 Jul; 11(7):e049688. PubMed ID: 34266843
[TBL] [Abstract][Full Text] [Related]
9. Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus-a study protocol.
Suleiman N; Alkasem M; Al Amer Z; Salameh O; Al-Thani N; Hamad MK; Baagar K; Abdalhakam I; Othman M; Dughmosh R; Al-Mohanadi D; Al Sanousi A; Bashir M; Chagoury O; Taheri S; Abou-Samra AB
Trials; 2022 Jun; 23(1):504. PubMed ID: 35710428
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of smartphone application-based self-management interventions in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
He Q; Zhao X; Wang Y; Xie Q; Cheng L
J Adv Nurs; 2022 Feb; 78(2):348-362. PubMed ID: 34324218
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a Digital Health Tool for Titration of Basal Insulin in People With Type 2 Diabetes: Rationale and Design of a Randomized Controlled Trial.
Hermanns N; Ehrmann D; Finke-Gröne K; Roos T; Freckmann G; Kulzer B
J Diabetes Sci Technol; 2023 Jan; ():19322968221148756. PubMed ID: 36602040
[TBL] [Abstract][Full Text] [Related]
12. App to support Recovery in Early Intervention Services (ARIES) study: protocol of a feasibility randomised controlled trial of a self-management Smartphone application for psychosis.
Steare T; O'Hanlon P; Eskinazi M; Osborn D; Lloyd-Evans B; Jones R; Rostill H; Amani S; Johnson S
BMJ Open; 2019 Mar; 9(3):e025823. PubMed ID: 30898825
[TBL] [Abstract][Full Text] [Related]
13. Effect of a lifestyle-focused electronic patient support application for improving risk factor management, self-rated health, and prognosis in post-myocardial infarction patients: study protocol for a multi-center randomized controlled trial.
Gonzalez M; Sjölin I; Bäck M; Ögmundsdottir Michelsen H; Tanha T; Sandberg C; Schiopu A; Leosdottir M
Trials; 2019 Jan; 20(1):76. PubMed ID: 30678709
[TBL] [Abstract][Full Text] [Related]
14. An information and communication technology-based centralized clinical trial to determine the efficacy and safety of insulin dose adjustment education based on a smartphone personal health record application: a randomized controlled trial.
Kim G; Bae JC; Yi BK; Hur KY; Chang DK; Lee MK; Kim JH; Jin SM
BMC Med Inform Decis Mak; 2017 Jul; 17(1):109. PubMed ID: 28720103
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial on a nurse-led smartphone-based self-management programme for people with poorly controlled type 2 diabetes: A study protocol.
Wang W; Seah B; Jiang Y; Lopez V; Tan C; Lim ST; Ren H; Khoo YH
J Adv Nurs; 2018 Jan; 74(1):190-200. PubMed ID: 28727183
[TBL] [Abstract][Full Text] [Related]
16. Organisational models supported by technology for the management of diabetic disease and its complications in a diabetic clinic setting: study protocol for a randomised controlled trial targeting type 2 diabetes individuals with non-ideal glycaemic values (Telemechron study).
Giovanazzi A; Gios L; Mastellaro M; Gentilini MA; Valent F; Condini S; Bincoletto G; Bacchiega A; Zorzi A; Malfatti G; Perini F; Eccher C; Marchesoni M; Dall'Alda M; Orrasch M; Conforti D; Inchiostro S
Trials; 2023 Aug; 24(1):513. PubMed ID: 37563665
[TBL] [Abstract][Full Text] [Related]
17. Development of an information system and mobile application for the care of type 2 diabetes patients at the primary care level for the health sector in Mexico: study protocol for a randomized controlled, open-label trial.
Barengo NC; Apolinar LM; Estrada Cruz NA; Fernández Garate JE; Correa González RA; Diaz Valencia PA; Gonzalez CAC; Rodriguez JAG; González NC;
Trials; 2022 Apr; 23(1):253. PubMed ID: 35379298
[TBL] [Abstract][Full Text] [Related]
18. A randomized wait-list control trial to evaluate the impact of a mobile application to improve self-management of individuals with type 2 diabetes: a study protocol.
Desveaux L; Agarwal P; Shaw J; Hensel JM; Mukerji G; Onabajo N; Marani H; Jamieson T; Bhattacharyya O; Martin D; Mamdani M; Jeffs L; Wodchis WP; Ivers NM; Bhatia RS
BMC Med Inform Decis Mak; 2016 Nov; 16(1):144. PubMed ID: 27842539
[TBL] [Abstract][Full Text] [Related]
19. Mobile Exergaming for Health-Effects of a serious game application for smartphones on physical activity and exercise adherence in type 2 diabetes mellitus-study protocol for a randomized controlled trial.
Höchsmann C; Walz SP; Schäfer J; Holopainen J; Hanssen H; Schmidt-Trucksäss A
Trials; 2017 Mar; 18(1):103. PubMed ID: 28264717
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
